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Introduction: A small but signiﬁcant number of infants with cystic ﬁbrosis (CF)
require neonatal surgery to relieve bowel obstruction from meconium ileus (MI).
This often results in stoma formation to encourage feeding, weight gain and
recycling of stoma output. We have undertaken a retrospective review to determine
the impact of time to stoma closure on nutritional status at 12 months of age.
Methods: A retrospective case note review of patients currently attending the Royal
Liverpool Children’s Hospital Regional CF Clinic (n, 282). We recorded duration
of stoma and weight centile at three stages: stoma formation, closure, and at 12
month review. Complications of stoma and hospital stay were also noted. Stoma
duration less than 8 weeks was classed as early closure (E) and more than 8 weeks
as late (L). The change in weight centile at 12 month review was used as a measure
of nutritional outcome.
Results: 48 children presented with MI (1990–2007); data were available for 26
included in the study. The early and late closure groups consisted of 19 (median
time to closure 5 weeks) and 7 patients (13 weeks) respectively. 63% of the early
closure group showed an increased weight centile at 12 months compared to 57%
of the late group. Stoma duration did not affect post-closure hospital stay. Late
stoma closure was associated with increased cases of post closure obstruction (E
vs. L; 15.8% vs. 57.1%).
Conclusion: This review suggests that the time to stoma closure does not impact
signiﬁcantly on subsequent nutritional status. More studies are needed to determine
the optimal post-operative management in this challenging group of children.
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A diet therapy and the use of pancreatic enzymes can promote an adequate
nutritional status in children with cystic ﬁbrosis − CF.
This study investigated the association between the use of oral protein calorie
supplementation and the nutritional status progression of patients with CF treated
with pancreatic enzymes, according to the international recommendations.
A total of 149 children aged 1 month to 18 years (mean: 8.9±5.3 years) were
evaluated at baseline and after 9 months of intervention. Z-scores for the weight-for-
age, height-for-age, weight-for-height and Body Mass Index-for-age were used to
characterize the nutritional status. Multiple regression analysis was used to correlate
the supplementation and the nutritional status progression, controlled by pancreatic
lipase intake, age and sex.
18.1% of the children were wasting at baseline, and 3.2% after 9 months of study.
22.7% of children were underweight before and 15.0% after 9 months of research.
22.6% of the children were stunting before and 15.0% after 9 months. In the
multivariate model, the protein supplementation was associated with the weight-for-
age improvement (b = 0.241; p = 0.021) and the calorie supplementation conjugated
to the daily dietetic ingestion was associated with weight gain (b = 0.583; p< 0.001)
We observed that the supplementations improved the nutritional status of the group
studied. As a long term parameter the stature achieving was associated with the
pancreatic lipase intake.
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Introduction: Pre and post diabetic decline is a feature of cystic ﬁbrosis-related
diabetes (CFRD). We examined the nutritional and clinical impact of aggressive
nutritional intervention on early and late acquisition of CFRD in a screened adult
population.
Method: We report 17 patients with CFRD1 (continued growth at entry) v 31
patients CFRD2 (completed growth), each matched to control populations for age,
sex, pseudomonas status.
Mean age at diagnosis (CFRD1) 21.9+3.7 yrs v (CFRD2) 28.3+5.6 yrs. Nutritional
intervention was initiated in agreement with patients, according to UK consensus
guidelines. Nutritional and clinical indices were recorded annually from 6 yrs pre
to 2 yrs post diagnosis and analysed using repeated measures ANOVA.
Results: In the 6 yrs to diagnosis, BMI (CFRD1) remained consistently below
CFRD2 [(F1,44) = 15, p< 0.001]. No differences in FEV1 [(F6,33) = 21, p = 0.3]
or iv antibiotic therapy [(F1,38) = 0.02, p = 0.9] were evident, but FEV1 deviated
increasingly between the younger and older group over time [(F6,33) = 3, p = 0.009].
A rapid decline in FEV1 (CFRD1) at 1 yr pre-diagnosis (46.9% to 41.5% diff = 5.4,
CI 1.6 to 6.5, p = 0.001), stabilized on insulin therapy. FEV1 (CFRD2) remained
stable as a % of control values throughout the pre-diabetic period. Enteral feeding
intensiﬁed for both groups and was signiﬁcantly greater in CFRD1 at diagnosis
[65% v 32%, OR 4.5, CI 1.1−19.3, p = 0.02).
Conclusion: Aggressive nutritional intervention prevents nutritional decline in older
but not younger adults with CFRD. Early acquisition of CFRD results in signiﬁcant
deviation in lung function and greater rate of pulmonary decline in younger adults.
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Cystic ﬁbrosis-related diabetes (CFRD) is a common complication of Cystic
ﬁbrosis (CF). CFRD adversely affects life expectancy, pulmonary function and body
weight. Insulin is the recommended treatment choice for the management of CFRD.
However glycaemic control is adversely affected by steroid therapy, respiratory
infection, dietary habits and patients’ concordance with treatment.
Continual glucose monitoring (CGMS) was used to obtain blood glucose proﬁles
in 27 patients who had poor glycaemic control (HbA1c >7%), suspected CFRD but
normal ﬁngerstix blood sugar measurements, recurrent hypoglycaemia attacks and
those on overnight enteral feeds.
27 patients (17 female) wore the Minimed Gold CGMS for 72 hours and completed
a food and activity diary. Following analysis of glucose proﬁles, these were the
recommendations:
– 7 commenced insulin therapy
– 5 were changed to twice daily (BD) background insulin
– 8 were encouraged to increase their bolus insulin dose
– 1 changed to basal bolus insulin from BD insulin
– 3 stopped insulin therapy
– 8 received dietary advice only
As a result of CGMS 24 patients changed their dietary intake and insulin therapy.
14/27 patients had erratic blood sugar proﬁles explained by overcorrection of
hypoglycaemic symptoms and rebound hyperglycaemia. Subsequently resources
have been produced to improve patients’ knowledge of hypoglycaemia, its symptoms
and the most effective treatment. We now have a protocol for the treatment of
hypoglycaemia available on patient information prescribing systems, in all in patient
rooms and include it in induction training for nursing staff. As patients with CFRD
are living longer our aim is to increase dietetic input along with a newly appointed
diabetes specialist nurse to provide patients with the knowledge to empower them
to achieve optimal glycaemic control.
